Shares in Novo Nordisk, the Danish maker of Ozempic and Wegovy, tumbled after studies showed the active ingredient in its hit ...
Novo Nordisk A/S said a next-generation diabetes shot lowered patients’ blood sugar and helped them lose weight in a study ...
Dual glucagon (GCG) and GLP-1 agonist mazdutide is already approved for both type 2 diabetes and obesity in China at doses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback